BackgroundCheck.run
Search For

David J Junker DeceasedEl Cajon, CA

Known as:
David Joseph Junker
Related to:
Nicole Jo Junker 41 Jennifer J Mulcahy 43

David Junker Phones & Addresses

El Cajon, CA   

Lakeside, CA   

Get Report
Control this profile

Mentions for David J Junker

Career records & work history

Medicine Doctors

David M. Junker

Specialties:
Pain Management
Work:
Marshfield ClinicMarshfield Clinic Eau Claire Center Multi Specialty
2116 Craig Rd, Eau Claire, WI 54701
715-8584700 (phone) 715-8584520 (fax)
Site
Education:
Medical School
Loma Linda University School of Medicine
Graduated: 1999
Languages:
English, Spanish
Description:
Dr. Junker graduated from the Loma Linda University School of Medicine in 1999. He works in Eau Claire, WI and specializes in Pain Management. Dr. Junker is affiliated with Ministry Sacred Heart Hospital.

Resumes & CV records

Resumes

David Junker Photo 44

David Junker

Position:
Head of Biologics Technology at EMD Millipore
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
EMD Millipore since Oct 2011
Head of Biologics Technology EMD Millipore Jan 2011 - Oct 2011
Head of Manufacturing Technology Millipore 2007 - Dec 2010
Sr. Manager Invitrogen 2004 - 2007
Sr. Manager Schering-Plough Pharmaceuticals 1990 - 2004
Assoc Principle Scientist
Education:
San Diego State University-California State University
MS, Biology, Emphasis in Molecular Biology University of California, San Diego
BA, Biochemistry and Cell Biology University of Phoenix
MBA, Business
David Junker Photo 45

David Junker

Location:
United States

Publications & IP owners

Wikipedia

David Junker Photo 46

David Junker Wikipdia A Enciclopdia Livre

- [ Translate this page ] David Junker maestro com PhD em Educao Musical e atual professor da Universidade de Braslia, onde ministra aulas de Regncia, Canto Coral, Prtica ...

Us Patents

Recombinant Swinepox Virus

US Patent:
6497882, Dec 24, 2002
Filed:
Jun 7, 1995
Appl. No.:
08/472679
Inventors:
Mark D. Cochran - Carlsbad CA
David E. Junker - San Diego CA
Assignee:
Syntro Corporation - San Diego CA
International Classification:
A61K 3912
US Classification:
4241991, 424 932, 4352351, 4353201
Abstract:
This invention provides a recombinant swinepox virus comprising a foreign DNA sequence inserted into the swinepox virus genomic DNA, wherein the foreign DNA sequence is inserted within a HindIII K fragment of the swinepox virus genomic DNA and is capable of being expressed in a swinepox virus infected host cell. The invention further provides homology vectors, vaccines and methods of immunization.

Neutralizing Gdf8 Epitope-Based Growth Enhancing Vaccine

US Patent:
7371726, May 13, 2008
Filed:
Dec 21, 2004
Appl. No.:
11/019001
Inventors:
David E. Junker - San Diego CA, US
Mark D. Cochran - Carlsbad CA, US
Assignee:
Schering-Plough Animal Health Corporation - Summit NJ
International Classification:
A61K 39/395
A61K 38/16
A61K 38/18
C07K 14/00
C07K 14/475
US Classification:
514 12, 514 2, 514 8, 514 13, 4241301, 4241391, 4241411, 4241421, 530300, 530324, 530326
Abstract:
The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.

Plant Virus Coat Fusion Proteins With Gdf8 Epitopes And Vaccines Thereof

US Patent:
7432079, Oct 7, 2008
Filed:
Dec 21, 2005
Appl. No.:
11/314397
Inventors:
David E. Junker - San Diego CA, US
Mark D. Cochran - Carlsbad CA, US
Mark L. Smith - Davis CA, US
Kenneth E. Palmer - Vacaville CA, US
Gregory P. Pogue - Vacaville CA, US
Assignee:
Schering-Plough Animal Health Corporation - Summit NJ
International Classification:
C12N 15/62
C12N 15/63
C12N 5/10
C12N 1/19
C12N 1/21
C07K 14/00
US Classification:
435 697, 435419, 435414, 4352523, 43525411, 4353201, 536 231, 536 234, 530350
Abstract:
The invention provides a fusion protein comprising a plant virus coat protein and a GDF8 peptide domain, or antigenic fragment of the GDF8 peptide domain. Plant virus vectors expressing the fusion protein and methods of using these vectors are also provided.

Nucleic Acids Encoding Neutralizing Gdf8 Epitope-Based Peptides And Fusion Proteins

US Patent:
7585648, Sep 8, 2009
Filed:
Apr 2, 2008
Appl. No.:
12/061012
Inventors:
David E. Junker - San Diego CA, US
Mark D. Cochran - Carlsbad CA, US
Assignee:
Schering-Plough Animal Health Corporation - Summit NJ
International Classification:
C12N 15/11
C12N 15/62
C12N 15/63
C12N 15/64
C12N 1/21
C12N 5/10
US Classification:
435 697, 435 691, 4353201, 435325, 4352523, 536 231, 536 234, 530300
Abstract:
The invention provides new, specific nucleic acids encoding antigenic peptides from the protein GDF8. The invention also provides nucleic acids encoding fusion proteins comprising the new peptides, immunogens and vaccines based on the nucleic acids encoding new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.

Neutralizing Gdf8 Epitope-Based Growth Enhancing Vaccine

US Patent:
7892561, Feb 22, 2011
Filed:
Aug 4, 2009
Appl. No.:
12/535298
Inventors:
David E. Junker - San Diego CA, US
Mark D. Cochran - Carlsbad CA, US
Assignee:
Schering-Plough Animal Health Corporation - Summit NJ
International Classification:
A61K 39/00
A61K 38/16
US Classification:
4241921, 4241851, 530300, 530324, 530326, 435 697
Abstract:
The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.

Neutralizing Epitope-Based Growth Enhancing Vaccine

US Patent:
2009020, Aug 20, 2009
Filed:
Aug 22, 2008
Appl. No.:
12/196935
Inventors:
David E. Junker - San Diego CA, US
Mark D. Cochran - Carlsbad CA, US
Mark L. Smith - Davis CA, US
Kenneth E. Palmer - Vacaville CA, US
Gregory P. Pogue - Vacaville CA, US
International Classification:
A61K 39/00
C07K 14/005
C07K 16/00
C07H 21/04
C12N 15/63
C12N 5/10
C12N 5/04
C12P 21/04
US Classification:
4241921, 530350, 5303873, 536 234, 4353201, 435419, 435414, 435 697
Abstract:
The invention provides a fusion protein comprising a plant virus coat protein and a GDF8 peptide domain, or antigenic fragment of the GDF8 peptide domain. Plant virus vectors expressing the fusion protein and methods of using these vectors are also provided.

Recombinant Swinepox Virus

US Patent:
6221361, Apr 24, 2001
Filed:
Jul 25, 1996
Appl. No.:
8/686968
Inventors:
Mark D. Cochran - Carlsbad CA
David E. Junker - San Diego CA
Assignee:
Syntro Corporation - Lenexa KS
International Classification:
A61K 39275
C12N 701
C12N 1586
US Classification:
4241991
Abstract:
This invention provides a recombinant swinepox virus comprising a foreign DNA inserted into a swinepox virus genomic DNA, wherein the foreign DNA is inserted into an EcoRI site within the approximately 3. 2 Kb subfragment of the HindIII K fragment of the swinepox virus genomic DNA and is capable of being expressed in a swinepox virus infected host cell. The invention further provides a recombinant swinepox virus designated S-SPV-120, S-SPV-121, S-SPV-122, S-SPV-127, and S-SPV-128. The invention further provides vaccines and methods of immunization of the recombinant swinepox virus.

Recombinant Fowlpox Virus S-Fpv-043 And Uses Thereof

US Patent:
6123949, Sep 26, 2000
Filed:
Jun 7, 1995
Appl. No.:
8/479869
Inventors:
Mark D. Cochran - Carlsbad CA
David E. Junker - San Diego CA
International Classification:
A61K 39275
A61K 39285
A61K 3912
US Classification:
4242321
Abstract:
The present invention provides a recombinant fowlpox virus designated S-FPV-043 (ATCC Accession No. VR 2395). A vaccine useful for immunizing an animal against fowlpox virus and Newcastle disease virus is provided which comprises an effective immunizing amount of S-FPV-043 and a suitable carrier. A method of immunizing an animal against fowlpox virus and Newcastle disease virus is also provided which comprises administering to the animal an effective immunizing dose of the vaccine.

Possible Relatives

Deborah N Junker  Eileen J Junker  Elizabeth M Junker  Elmer Junker  Gary L Junker  Glenn E Junker  Gregory C Junker  David Last  David W Johnson  David Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.